RNS Number: 7803 D GlaxoSmithKline PLC 21 February 2020 GlaxoSmithKline plc. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 6576 D GlaxoSmithKline PLC 20 February 2020 GlaxoSmithKline plc. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 6475 D GlaxoSmithKline PLC 20 February 2020 GlaxoSmithKline plc. Conditional Share Awards and Shares withheld or sold to meet tax liabilities. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 6484 D GlaxoSmithKline PLC 20 February 2020 GlaxoSmithKline plc. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 5246 D GlaxoSmithKline PLC 19 February 2020 GlaxoSmithKline plc. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 5180 D GlaxoSmithKline PLC 19 February 2020 GlaxoSmithKline plc. Vesting of Performance Share Plan Awards. This notification sets out the vesting details of awards over Ordinary Shares and American Depositary Shares made to Persons Discharging Managerial Responsibilities and their Persons Closely Associated in 2017 under the...
RNS Number: 5175 D GlaxoSmithKline PLC 19 February 2020. 2020 Performance Share Plan Award and 2020 Performance Measures. 2020 Performance Share Plan Award.
RNS Number: 5165 D GlaxoSmithKline PLC 19 February 2020 GlaxoSmithKline plc. Vesting of Deferred Annual Bonus Plan Mandatory and Matching Awards. This notification sets out the vesting details for the Chief Executive Officer and other Persons Discharging Managerial Responsibilities of Deferred Bonus Awards over Ordinary Shares and American...
RNS Number: 5160 D GlaxoSmithKline PLC 19 February 2020 GlaxoSmithKline plc. Deferred Annual Bonus Plan Awards. On 14 February 2020, the Company granted awards to the Executive Directors and other Persons Discharging Managerial Responsibilities listed below.
RNS Number: 8247 C GlaxoSmithKline PLC 12 February 2020 GlaxoSmithKline plc. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 6645 C GlaxoSmithKline PLC 11 February 2020 GlaxoSmithKline plc. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 5495 C GlaxoSmithKline PLC 11 February 2020 GlaxoSmithKline plc. On 10 February 2020, the Company transferred 25,800,000 ordinary shares of 25 pence each that were held by the Company in treasury to JPMorgan Chase Bank, N.A. the depositary of the Company's American depositary receipts programme, to procure the issuance and transfer of 12,900,000...
RNS Number: 2544 C GlaxoSmithKline PLC 06 February 2020 GlaxoSmithKline plc. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 1100 C GlaxoSmithKline PLC 05 February 2020 GlaxoSmithKline plc. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 0578 C GlaxoSmithKline PLC 05 February 2020. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 7940 B GlaxoSmithKline PLC 03 February 2020 GlaxoSmithKline plc. GSK publishes provisional dividend dates. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 7320 B GlaxoSmithKline PLC 03 February 2020 GlaxoSmithKline plc. The Company's issued share capital as at 31 January 2020 consisted of 5,384,058,616 shares of 25 pence each, of which 393,505,950 Ordinary Shares were held in Treasury.. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 8051 Z GlaxoSmithKline PLC 14 January 2020 GlaxoSmithKline plc. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 7967 Z GlaxoSmithKline PLC 14 January 2020 GlaxoSmithKline plc. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 7922 Z GlaxoSmithKline PLC 14 January 2020 GlaxoSmithKline plc. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
Bid
-
-
-
Ask
  • High
    -
  • OPEN
    -
  • VOL
    -
  • MKT CAP
    -m
  • LOW
    -
  • CLOSE
    -
  • AVG VOL
    -
  • SHARES IN ISSUE
    4.97B

Company Profile

UK-based GlaxoSmithKline is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.

Classification

Market Indices-

Locations

HQ
980 Great West Road
Middlesex
Brentford
TW8 9GS
Watchlist